Tanvex BioPharma, Inc removed from Taiwan TAIEX Index.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
44 TWD | +4.51% |
|
+10.83% | -32.41% |
06-19 | Tanvex BioPharma, Inc. Appoints Val Chen as Corporate Governance Officer, Effective July 1, 2024 | CI |
06-19 | Tanvex BioPharma, Inc. Announces Change of Audit Committee Members | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
18,583 PTS | +0.76% | -1.52% | - | ||
816.1 USD | +0.36% | -2.92% | - | ||
44 TWD | +4.51% | +10.83% | 212M | ||
1st Jan change | Capi. | |
---|---|---|
-32.41% | 212M | |
+16.20% | 122B | |
+21.53% | 116B | |
+22.18% | 27.03B | |
-21.84% | 20.36B | |
-16.89% | 16.43B | |
-18.06% | 15.91B | |
-44.74% | 15.6B | |
+61.56% | 14.94B | |
+3.18% | 13.59B |
- Stock Market
- Equities
- 6541 Stock
- News Tanvex BioPharma, Inc.
- Tanvex BioPharma, Inc.(TWSE: 6541) dropped from Taiwan TAIEX Index